Membrane Localization of Src Homology 2-containing Inositol 5'-phosphatase 2 Via Shc Association is Required for the Negative Regulation of Insulin Signaling in Rat1 Fibroblasts Overexpressing Insulin Receptors
Overview
Molecular Biology
Authors
Affiliations
Lipid phosphatase SHIP2 [Src homology 2 (SH2)-containing inositol 5'-phosphatase 2] has been shown to be a physiologically critical negative regulator of insulin signaling. We investigated the molecular mechanism by which SHIP2 negatively regulates insulin-induced phosphorylation of Akt, a key downstream molecule of phosphatidylinositol 3-kinase important for the biological action of insulin. Overexpression of wild-type SHIP2 (WT-SHIP2) inhibited insulin-induced phosphorylation of Akt at both Thr(308) and Ser(473) in Rat1 fibroblasts expressing insulin receptors. The degree of inhibition was less in the cells expressing either a mutant SHIP2 with R47Q change (R/Q-SHIP2) in the SH2 domain, or a mutant SHIP2 with Y987F change (Y/F-SHIP2) in the C-terminal tyrosine phosphorylation site. However, on addition of a myristoylation signal, WT-SHIP2, R/Q-SHIP2, and Y/F-SHIP2 all efficiently inhibited insulin-induced Akt phosphorylation at both residues, whereas a 5'-phosphatase-defective mutant SHIP2 (deltaIP-SHIP2) with the myristoylation signal did not. Interestingly, the degree of inhibition of Akt phosphorylation by R/Q-SHIP2 and Y/F-SHIP2 is well correlated with the extent of their association with Shc. In addition, overexpression of WT-Shc increased the insulin-induced association of SHIP2 with Shc, whereas a decrease in the amount of Shc on expression of antisense Shc mRNA led to a reduction in the SHIP2-Shc association. Furthermore, the inhibitory effect on insulin-induced Akt phosphorylation by WT-SHIP2 was decreased in antisense-Shc cells. These results indicate that the membrane localization of SHIP2 with its 5'-phosphatase activity is required for negative regulation of insulin-induced Akt phosphorylation and that the localization is regulated, at least in part, by the association of SHIP2 with Shc in Rat1 fibroblasts.
Azzi A FEBS Open Bio. 2020; 10(10):2191-2205.
PMID: 32881386 PMC: 7530381. DOI: 10.1002/2211-5463.12967.
SHIPping out diabetes-Metformin, an old friend among new SHIP2 inhibitors.
Lehtonen S Acta Physiol (Oxf). 2019; 228(1):e13349.
PMID: 31342643 PMC: 6916339. DOI: 10.1111/apha.13349.
INPPL1 gene mutations in opsismodysplasia.
Fradet A, Fitzgerald J J Hum Genet. 2016; 62(2):135-140.
PMID: 27708270 PMC: 5268411. DOI: 10.1038/jhg.2016.119.
5'-Inositol phosphatase SHIP2 recruits Mena to stabilize invadopodia for cancer cell invasion.
Rajadurai C, Havrylov S, Coelho P, Ratcliffe C, Zaoui K, Huang B J Cell Biol. 2016; 214(6):719-34.
PMID: 27597754 PMC: 5021089. DOI: 10.1083/jcb.201501003.
Yoshinaga S, Ohkubo T, Sasaki S, Nuriya M, Ogawa Y, Yasui M J Neurosci. 2012; 32(34):11643-56.
PMID: 22915108 PMC: 6703763. DOI: 10.1523/JNEUROSCI.0738-12.2012.